These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Neglected hepatitis E and typhoid vaccines. Basnyat B Lancet; 2010 Sep; 376(9744):869. PubMed ID: 20833293 [No Abstract] [Full Text] [Related]
5. Hepatitis E vaccine: WHO position paper, May 2015. Wkly Epidemiol Rec; 2015 May; 90(18):185-200. PubMed ID: 25935931 [No Abstract] [Full Text] [Related]
6. Protection against hepatitis E virus infection by naturally acquired and vaccine-induced immunity. Zhang J; Zhang XF; Zhou C; Wang ZZ; Huang SJ; Yao X; Liang ZL; Wu T; Li JX; Yan Q; Yang CL; Jiang HM; Huang HJ; Xian YL; Shih JW; Ng MH; Li YM; Wang JZ; Zhu FC; Xia NS Clin Microbiol Infect; 2014 Jun; 20(6):O397-405. PubMed ID: 24118636 [TBL] [Abstract][Full Text] [Related]
7. HEV study protocol : design of a cluster-randomised, blinded trial to assess the safety, immunogenicity and effectiveness of the hepatitis E vaccine HEV 239 (Hecolin) in women of childbearing age in rural Bangladesh. Zaman K; Dudman S; Stene-Johansen K; Qadri F; Yunus M; Sandbu S; Gurley ES; Overbo J; Julin CH; Dembinski JL; Nahar Q; Rahman A; Bhuiyan TR; Rahman M; Haque W; Khan J; Aziz A; Khanam M; Streatfield PK; Clemens JD BMJ Open; 2020 Jan; 10(1):e033702. PubMed ID: 31959609 [TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large-scale, randomised, double-blind placebo-controlled, phase 3 trial. Zhu FC; Zhang J; Zhang XF; Zhou C; Wang ZZ; Huang SJ; Wang H; Yang CL; Jiang HM; Cai JP; Wang YJ; Ai X; Hu YM; Tang Q; Yao X; Yan Q; Xian YL; Wu T; Li YM; Miao J; Ng MH; Shih JW; Xia NS Lancet; 2010 Sep; 376(9744):895-902. PubMed ID: 20728932 [TBL] [Abstract][Full Text] [Related]
9. U.S. Military sponsored vaccine trials and la resistance in Nepal. Andrews J Am J Bioeth; 2005; 5(3):W1-3. PubMed ID: 16006352 [No Abstract] [Full Text] [Related]
10. Perspectives of vaccination against hepatitis E. Safary A Intervirology; 2001; 44(2-3):162-6. PubMed ID: 11509877 [TBL] [Abstract][Full Text] [Related]
11. Global Advisory Committee on Vaccine Safety, 11-12 June 2014. Wkly Epidemiol Rec; 2014 Jul; 89(29):325-35. PubMed ID: 25045773 [No Abstract] [Full Text] [Related]
12. Hepatitis E: a neglected threat. Myint KS; Gibbons RV Trans R Soc Trop Med Hyg; 2008 Mar; 102(3):211-2. PubMed ID: 17658568 [TBL] [Abstract][Full Text] [Related]
13. [Hepatitis E: an emerging viral disease]. Soriano V; Barreiro P Med Clin (Barc); 2014 Jul; 143(1):22-4. PubMed ID: 24656852 [No Abstract] [Full Text] [Related]
14. Hepatitis E, a vaccine-preventable cause of maternal deaths. Labrique AB; Sikder SS; Krain LJ; West KP; Christian P; Rashid M; Nelson KE Emerg Infect Dis; 2012 Sep; 18(9):1401-4. PubMed ID: 22931753 [TBL] [Abstract][Full Text] [Related]
15. Hepatitis A and E: not to be forgotten. Asghar RJ East Mediterr Health J; 2014 Apr; 20(3):212-3. PubMed ID: 24950080 [No Abstract] [Full Text] [Related]
16. Hepatitis: Hepatitis E vaccination--is HEV 239 the breakthrough? Wedemeyer H; Pischke S Nat Rev Gastroenterol Hepatol; 2011 Jan; 8(1):8-10. PubMed ID: 21212772 [No Abstract] [Full Text] [Related]
17. Nepal calls the shots in hepatitis E virus vaccine trial. Stevenson P Lancet; 2000 May; 355(9215):1623. PubMed ID: 10821375 [No Abstract] [Full Text] [Related]
18. Hepatitis E vaccine debuts. Park SB Nature; 2012 Nov; 491(7422):21-2. PubMed ID: 23128204 [No Abstract] [Full Text] [Related]
19. Safety and efficacy of a recombinant hepatitis E vaccine. Shrestha MP; Scott RM; Joshi DM; Mammen MP; Thapa GB; Thapa N; Myint KS; Fourneau M; Kuschner RA; Shrestha SK; David MP; Seriwatana J; Vaughn DW; Safary A; Endy TP; Innis BL N Engl J Med; 2007 Mar; 356(9):895-903. PubMed ID: 17329696 [TBL] [Abstract][Full Text] [Related]